No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Non-small cell lung cancer based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer
- Lung cancer and mesothelioma
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion
- Excluding asthma or asthma-COPD overlap
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 55170 | 14551 | 38739 |
Only index persons | 26307 | 9690 | 16617 |
Unadjusted period prevalence (%) | |||
Whole population | 0.94 | 0.42 | 1.08 |
Only index persons | 0.53 | 0.36 | 0.63 |
Median age at first event (years) | |||
Whole population | 68.26 | 68.97 | 68.07 |
Only index persons | 70.15 | 69.88 | 70.30 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 5820 | 1691 | 4129 |
Unadjusted period prevalence (%) | 1.66 | 0.66 | 2.07 |
Median age at first event (years) | 71.12 | 68.89 | 72.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_LUNG_NONSMALL_EXALLC and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_LUNG_NONSMALL_EXALLC | 15.73 [12.97, 19.08] | < 0.001 |
Birth year | 0.99 [0.98, 1.0] | 0.014 |
During the follow-up period (1.1.1998 — 31.12.2019), 7450 out of 10073 females with C3_LUNG_NONSMALL_EXALLC died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_LUNG_NONSMALL_EXALLC | 14.614 [11.83, 18.06] | < 0.001 |
Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 16926 out of 19954 males with C3_LUNG_NONSMALL_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_LUNG_NONSMALL_EXALLC.N-year risk | Females | Males |
---|---|---|
1 | 1.061% | 2.881% |
5 | 6.752% | 13.338% |
10 | 15.993% | 29.912% |
15 | 28.691% | 50.197% |
20 | 45.126% | 68.351% |
Relationships between endpoints
↥Index endpoint: C3_LUNG_NONSMALL_EXALLC – Non-small cell lung cancer
GWS hits: 5